From July 13 (Wednesday) to July 15 (Friday), 2022, we plan to provide a wide introduction to the services available!
We will be exhibiting at the 24th Interphex Japan held at Tokyo Big Sight. At this exhibition, we plan to broadly introduce the services that are available through Spira Pharma and the Astena Group. If you wish to have a meeting during the event, please contact our sales representative or use the inquiry form on our website. We sincerely look forward to your visit. 【Event Overview】 ■ Event Name: 24th Interphex Week Tokyo ■ Dates: July 13 (Wednesday) to July 15 (Friday), 2022, 10:00 AM to 6:00 PM (ends at 5:00 PM on the final day) ■ Venue: Tokyo Big Sight (3-11-1 Ariake, Koto-ku, Tokyo 135-0063) ■ Booth Number: 22-68 ■ Free Exhibition Invitation Ticket *If you do not have an invitation ticket, the admission fee is 5,000 yen per person. *For more details, please refer to the related link page or feel free to contact us.
Inquire About This Product
basic information
【Access】 ■Nearest Station - About a 7-minute walk from "Kokusai Tenjijo Station" on the Rinkai Line - About a 3-minute walk from "Tokyo Big Sight Station" on the Yurikamome Line *For more details, please refer to the related links page or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the related link page or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is a pharmaceutical CMC research and development contract company that spun out from the CMC research division of Takeda Pharmaceutical Company Limited in July 2017. We support excellent pharmaceutical development as experts in CMC research. Our research team consists of experts with extensive experience and achievements in process chemistry, formulation research and development, and analytical testing development related to CMC research. We provide high-level services and solutions tailored to our customers' needs across each process from the early stages of pharmaceutical development to application, while flexibly collaborating. We have established a collaborative system with partner companies, enabling us to offer a one-stop service. Please utilize us as a platform for your pharmaceutical development.
